157 related articles for article (PubMed ID: 34055488)
21. EZH2 suppresses insulinoma development by epigenetically reducing KIF4A expression via H3K27me3 modification.
Zhang S; Liu J; Li F; Yang M; Wang J
Gene; 2022 May; 822():146317. PubMed ID: 35182680
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of receptor tyrosine kinase-like orphan receptor 2 inhibits cell proliferation and colony formation in osteosarcoma cells by inducing arrest in cell cycle progression.
Huang J; Shi Y; Li H; Tan D; Yang M; Wu X
Oncol Lett; 2015 Dec; 10(6):3705-3711. PubMed ID: 26788194
[TBL] [Abstract][Full Text] [Related]
23. Enhanced expression of KIF4A in colorectal cancer is associated with lymph node metastasis.
Matsumoto Y; Saito M; Saito K; Kanke Y; Watanabe Y; Onozawa H; Hayase S; Sakamoto W; Ishigame T; Momma T; Kumamoto K; Ohki S; Takenoshita S
Oncol Lett; 2018 Feb; 15(2):2188-2194. PubMed ID: 29434924
[TBL] [Abstract][Full Text] [Related]
24. m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.
Ling Z; Chen L; Zhao J
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32266933
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signaling.
Cui X; Wang H; Wu X; Huo K; Jing X
J Ovarian Res; 2021 May; 14(1):71. PubMed ID: 34034774
[TBL] [Abstract][Full Text] [Related]
26. Silencing lncRNA ZFAS1 or elevated microRNA-135a represses proliferation, migration, invasion and resistance to apoptosis of osteosarcoma cells.
Zhao Z; Lin X; Tong Y; Li W
Cancer Cell Int; 2019; 19():326. PubMed ID: 31827400
[TBL] [Abstract][Full Text] [Related]
27. miR-495-3p inhibits the cell proliferation, invasion and migration of osteosarcoma by targeting C1q/TNF-related protein 3.
Zhao G; Zhang L; Qian D; Sun Y; Liu W
Onco Targets Ther; 2019; 12():6133-6143. PubMed ID: 31447563
[No Abstract] [Full Text] [Related]
28. Pan-Cancer analysis of TERT and Validation in Osteosarcoma Cell Lines.
Xie L; Yin W; Tang F; He M
Biochem Biophys Res Commun; 2023 Jan; 639():106-116. PubMed ID: 36476950
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p.
Yu Y; Wang L; Li Z; Zheng Y; Shi Z; Wang G
J Biochem Mol Toxicol; 2021 May; 35(5):e22734. PubMed ID: 33522065
[TBL] [Abstract][Full Text] [Related]
30. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
31. MiR-92a modulates proliferation, apoptosis, migration, and invasion of osteosarcoma cell lines by targeting Dickkopf-related protein 3.
Yu H; Song H; Liu L; Hu S; Liao Y; Li G; Xiao X; Chen X; He S
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30926679
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-1253 Suppresses Cell Proliferation Migration and Invasion of Osteosarcoma by Targeting MMP9.
Mo J; Zheng T; Lei L; Dai P; Liu J; He H; Shi J; Chen X; Guo T; Yuan B; Ji G
Technol Cancer Res Treat; 2021; 20():1533033821995278. PubMed ID: 34036868
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-185 inhibits proliferation, migration and invasion in human osteosarcoma MG63 cells by targeting vesicle-associated membrane protein 2.
Li L; Wang X; Liu D
Gene; 2019 May; 696():80-87. PubMed ID: 30721745
[TBL] [Abstract][Full Text] [Related]
34. MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT/mTOR pathway.
Wang L; Yang Y; Wang XM; Wang CQ; Zhang YM; Li BL
J Recept Signal Transduct Res; 2020 Dec; 40(6):584-590. PubMed ID: 32456526
[TBL] [Abstract][Full Text] [Related]
35. MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma.
Tesser-Gamba F; Lopes LJ; Petrilli AS; Toledo SR
Mol Carcinog; 2016 Nov; 55(11):1700-1713. PubMed ID: 26460937
[TBL] [Abstract][Full Text] [Related]
36. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
Han Y; Zhao X; Sun Y; Sui Y; Liu J
J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
[TBL] [Abstract][Full Text] [Related]
37. Nasopharyngeal carcinoma‑associated gene 6 inhibits cell viability, migration, invasion and induces apoptosis in osteosarcoma cells by inactivating the Wnt/β‑catenin signaling pathway.
Liu L; Wang R; Zhang Z; Wang X
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300077
[TBL] [Abstract][Full Text] [Related]
38. miR‑23b‑3p promotes the apoptosis and inhibits the proliferation and invasion of osteosarcoma cells by targeting SIX1.
Liu H; Wei W; Wang X; Guan X; Chen Q; Pu Z; Xu X; Wei A
Mol Med Rep; 2018 Dec; 18(6):5683-5692. PubMed ID: 30387818
[TBL] [Abstract][Full Text] [Related]
39. NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma.
Huang Z; Chen H; Wang S; Wei H; Wang X; Shen R; Wang Y; Lin R; Lin J
Front Pharmacol; 2021; 12():724923. PubMed ID: 34393801
[TBL] [Abstract][Full Text] [Related]
40. FKBP14 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
Huang Z; Li J; Du S; Tang Y; Huang L; Xiao L; Tong P
Oncotarget; 2016 Jun; 7(26):39872-39884. PubMed ID: 27223089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
